Lewiecki E Michael, Bilezikian John P, Clark Amanda, Collins Michael T, Kado Deborah M, Lane Joseph, Langdahl Bente, McClung Michael R, Snyder Peter J, Stein Emily M
New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
J Clin Densitom. 2025 Jan-Mar;28(1):101559. doi: 10.1016/j.jocd.2024.101559. Epub 2024 Dec 28.
The 24 Annual Santa Fe Bone Symposium (SFBS) was held in Santa Fe, New Mexico, USA, on August 2-3, 2024. This was a "hybrid" meeting, with in-person and real-time remote participants representing a broad range of geographical locations and medical disciplines. The focus was on new developments in the care of patients with osteoporosis, other metabolic bone diseases, and inherited skeletal disorders. The most current medical evidence was presented and discussed with consideration of implications for patient management. Topics included an update on clinical uses of osteoanabolic agents, management of patients discontinuing denosumab, bone health optimization for orthopedic surgery, estrogen and testosterone in the management of osteoporosis, osteoporosis treatment in the very old, overview of rare bone diseases, treat-to-target for osteoporosis, and a progress report on global activities of Bone Health ECHO. There were two highly interactive faculty panel discussions - one with case presentations by attendees and another with open microphone for all topics of interest. Endocrinology fellows, selected from attendees of the Santa Fe Fellows Workshop on Metabolic Bone Diseases, held the two days preceding the SFBS, participated with presentations of oral abstracts. Ancillary events addressed modern approaches to menopause and bone health, case studies of management of patients at very high fracture risk, and management of patients with rare bone diseases, such as hypophosphatasia, fibrodysplasia ossificans progressiva, X-linked hypophosphatemia, and hypoparathyroidism. These proceedings of the SFBS present the clinical highlights of the plenary sessions and the discussions that followed.
第24届圣达菲骨科学研讨会（SFBS）于2024年8月2日至3日在美国新墨西哥州圣达菲举行。这是一次“混合型”会议，现场参会者和实时远程参会者来自广泛的地理位置和医学学科。会议重点关注骨质疏松症、其他代谢性骨病和遗传性骨骼疾病患者护理的新进展。会上展示并讨论了最新的医学证据，并考虑了其对患者管理的影响。主题包括骨合成代谢药物临床应用的最新情况、停用地诺单抗患者的管理、骨科手术的骨健康优化、骨质疏松症管理中的雌激素和睾酮、高龄患者的骨质疏松症治疗、罕见骨病概述、骨质疏松症的达标治疗以及骨健康ECHO全球活动的进展报告。有两场高度互动的教员小组讨论——一场是参会者进行病例展示，另一场是就所有感兴趣的话题开放麦克风讨论。从在SFBS前两天举行的圣达菲代谢性骨病研究员研讨班的参会者中选出的内分泌科研究员，以口头摘要的形式参与了展示。辅助活动涉及更年期和骨健康的现代方法、极高骨折风险患者管理的案例研究以及罕见骨病患者的管理，如低磷酸酯酶症、进行性骨化性纤维发育不良、X连锁低磷血症和甲状旁腺功能减退症。SFBS的这些会议记录展示了全会的临床要点以及随后的讨论情况。
